ClinicalTrials.gg
Sign In

Newish Technology (Beijing) Co., Ltd. clinical trials

A subsidiary of Newish Biotech (Wuxi) Co., Ltd.

The registry lists 8 studies whose lead sponsor is Newish Technology (Beijing) Co., Ltd.. 7 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 25, 2026.

What it is testing

The drugs Newish Technology (Beijing) Co., Ltd.’s studies test, most open studies first — 2 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

All 8 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now788%
  • Completed113%

Phase

  • Phase 13
  • Phase 22

Where

  • China8

Over the years

  1. 18
  2. 19
  3. 20
  4. 21
  5. 22
  6. 23
  7. 324
  8. 25
  9. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Newish Technology (Beijing) Co., Ltd.8 studies

Something wrong with this grouping? Tell us on the Newish Biotech (Wuxi) Co., Ltd. page.

Studies

Recruiting first, then most recently updated. Showing 8 of 8. All Newish Biotech (Wuxi) Co., Ltd. studies →